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Abstract
Chronic kidney disease (CKD), impairment of kidney function, is a serious public health problem, 
and the assessment of genetic factors influencing kidney function has substantial clinical 
relevance. Here, we report a meta-analysis of genome-wide association studies for kidney 
function–related traits, including 71,149 east Asian individuals from 18 studies in 11 population-, 
hospital- or family-based cohorts, conducted as part of the Asian Genetic Epidemiology Network 
(AGEN). Our meta-analysis identified 17 loci newly associated with kidney function–related 
traits, including the concentrations of blood urea nitrogen, uric acid and serum creatinine and 
estimated glomerular filtration rate based on serum creatinine levels (eGFRcrea) (P < 5.0 × 10−8). 
We further examined these loci with in silico replication in individuals of European ancestry from 
the KidneyGen, CKDGen and GUGC consortia, including a combined total of ~110,347 
individuals. We identify pleiotropic associations among these loci with kidney function–related 
traits and risk of CKD. These findings provide new insights into the genetics of kidney function.
Chronic kidney disease—the impairment of kidney function—constitutes a serious public 
health burden on society worldwide, with increased risks of mortality and morbidity1, 2. 
Biochemical measures of kidney function that are commonly used in clinical practice 
include the concentrations of blood urea nitrogen, serum creatinine and uric acid and 
glomerular filtration rate (GFR). Heritability estimates have shown that genetic factors 
contribute significantly to interindividual variance in kidney function3, and recent 
developments in genome-wide association studies (GWAS) have identified a number of 
genetic loci associated with measurements of kidney function4, 5, 6, 7, 8, 9, 10, 11, 12, 13. 
However, most of these studies were conducted in populations of European 
ancestry4, 6, 7, 8, 10, 11, 12, 13, and the extension of GWAS approaches to non-European 
populations would provide an opportunity to discover additional loci. We report a large-
scale meta-analysis of GWAS and a replication study of kidney function–related traits 
involving 71,149 east Asian subjects performed by AGEN9, 14, 15, 16 in which 11 cohorts 
participated (BBJ, SP2, SiMES, SINDI, SCES, KARE, HEXA, TWSC, TWT2D, GenSalt 
and CAGE; Online Methods and Supplementary Note).
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In this study, we evaluated four kidney function–related traits (Supplementary Tables 1 and 
2): the concentrations of blood urea nitrogen (n = 57,178), uric acid (n = 33,074) and serum 
creatinine (n= 61.919) and eGFRcrea (n = 62,087). Blood urea nitrogen concentration 
reflects the amount of nitrogen in the blood and is related to protein metabolism, including 
excretion by the kidneys17. Uric acid is the end product of purine metabolism, and impaired 
renal excretion of uric acid leads to hyperuricemia. Epidemiological studies suggest that uric 
acid is a risk factor for various diseases, including gout and myocardial infarction13. Serum 
creatinine levels and eGFRcrea are the most common kidney function measures used for the 
definition of CKD1, 2, for which extensive genetic studies in European populations have 
been conducted4, 6, 7, 8.
The GWAS meta-analysis included 51,327 east Asian individuals and evaluated 
approximately 2.4 million autosomal SNPs with a minor allele frequency (MAF) of ≥0.01. 
These SNPs were obtained by imputation of genotypes on the basis of HapMap Phase 2 
panels (Supplementary Tables 3 and 4). The inflation factors of the test statistics were 
modest (λGC = 1.060, 1.072, 1.079 and 1.031 for blood urea nitrogen, serum creatinine, 
eGFRcrea and uric acid, respectively), which suggested that population structures did not 
have a substantial impact on the results of the meta-analysis. Quantile-quantile plots of the P 
values indicated notable discrepancies in their tails from those anticipated under the null 
hypothesis of no association, indicating the presence of significant associations in the meta-
analysis (Supplementary Fig. 1). We identified 25 associations that satisfied the genome-
wide significance threshold of P < 5.0 × 10−8. Of these, eight, seven, six and four genetic 
loci were found to associated with blood urea nitrogen, serum creatinine, eGFRcrea and uric 
acid, respectively (Supplementary Table 5).
We then performed an in silico replication study using data from an additional 19,822 east 
Asians for the loci that associated at P < 5.0 × 10−6 in the GWAS meta-analysis. Through 
the combined study of the GWAS meta-analysis and replication, we identified 32 significant 
associations at P < 5.0 × 10−8 (13, 8, 7 and 4 loci for blood urea nitrogen, serum creatinine, 
eGFRcrea and uric acid, respectively; Fig. 1 and Supplementary Table 5). We found that 
seven of these newly associated loci were associated with both serum creatinine 
concentration and eGFRcrea, with the same landmark SNPs involved at each locus, which 
reflects the close relationship between these two phenotypes (R2 = 0.76 for common log-
transformed values; Supplementary Table 6)1, 2. Among the loci identified in the combined 
analysis, associations at 15 loci were previously reported4, 5, 6, 7, 8, 9, 10, 11, 12, 13: LRIG1-
KBTBD8, BCL6-LPP, RSPO3 and SLC14A2 for blood urea nitrogen concentration (smallest 
P = 8.8 × 10−30 at BCL6-LPP); SHROOM3, WDR72, UMOD and BCAS3 for serum 
creatinine concentration (smallest P = 1.2 × 10−13 at WDR72); SHROOM3, WDR72, UMOD 
and BCAS3 for eGFRcrea (smallest P = 6.0 × 10−13 at WDR72); and SLC2A9, ABCG2 and 
SLC22A12 for uric acid concentration (smallest P = 1.6 × 10−65 at SLC2A9). At the UMOD 
locus, the rs12917707 variant associated with eGFRcrea in Europeans4, 7 had a low MAF 
(<0.01) and was not evaluated in our GWAS meta-analysis. However, we identified another 
variant that showed a significant association with eGFRcrea (P = 3.6 × 10−10 at rs11864909; 
MAF = 0.19; r2 = 0.02 with rs12917707).
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In addition, we identified 17 loci newly associated with kidney function–related traits (Table 
1 and Supplementary Fig. 2). Namely, we identified associations at nine loci for blood urea 
nitrogen concentration (MTX1-GBA, PAX8, MECOM,UNCX, MPPED2-DCDC5, C12orf51, 
WDR72, BCAS3 and GNAS at 1q22, 2q13, 3q26, 7p22, 11p14, 12q24.13, 15q21, 17q23 and 
20q13, respectively; smallest P = 4.5 × 10−16 at rs10767873 in MPPED2-DCDC5), four loci 
for serum creatinine concentration (the major histocompatibility (MHC) region, UNCX, 
MPPED2-DCDC5 and ALDH2 at 6p21, 7p22, 11p14 and 12q24.2, respectively; smallest P 
= 4.6 × 10−11 at rs10277115 in UNCX), three loci for eGFRcrea (the MHC region, UNCX 
and MPPED2-DCDC5 at 6p21, 7p22 and 11p14, respectively; smallest P = 1.0 × 10−10 at 
rs10277115 in UNCX) and one locus for uric acid concentration (MAF at 16q23, P = 1.1 × 
10−9 at rs889472). Combinations of these identified loci explained 1.3%, 0.54%, 0.55% and 
2.3% of interindividual variance in blood urea nitrogen, serum creatinine, eGFRcrea and 
uric acid, respectively.
To determine whether the associations that we observed were relevant to populations of 
European ancestry, we evaluated the newly associated loci (at P < 5.0 × 10−8 in our 
combined meta-analysis) in Europeans by using the results of studies by the KidneyGen (n = 
23,812 for serum creatinine concentration)6, CKDGen (n = 67,093 for eGFRcrea)7 and 
GUGC (n = 110,347 for uric acid concentration; A. Köttgen et al., personal communication) 
consortia. Nine of the 15 loci that reached P < 5.0 × 10−8 for serum creatinine, eGFRcrea 
and uric acid measures in our study also showed significant associations in the European 
study (P < 0.05/15 = 0.0033, Bonferroni correction for the number of loci with available 
results), including the MPPED2-DCDC5 locus for eGFRcrea (P= 5.3 × 10−8 at rs963837; 
Supplementary Table 5).
We also evaluated the loci previously reported to be associated with kidney function 
measures, after excluding the 14 loci that had already been identified in our study 
(Supplementary Table 7)4, 5, 6, 7, 8, 9, 10, 11, 12, 13. Of the 31 loci evaluated, we replicated 
associations at 8 loci in our study (P< 0.05/31 = 0.0016, Bonferroni correction for the 
number of loci), including in CPS1, RGS14, STC1, RNASEH2C-OVOL1 and SLC6A13 for 
eGFRcrea and GCKR, LRP2 and LRRC16A-SLC17A1 for uric acid concentration.
As the evaluated phenotypes reflect both common and unique biological aspects of kidney 
status, it is of interest to understand whether the loci associated with kidney function traits 
show pleiotropic patterns of associations18. We evaluated the associations of the identified 
loci within the evaluated kidney function–related traits and risk of stage 3+ CKD (defined as 
eGFRcrea of <60 ml/min/1.73 m2; Fig. 2, Table 2 and Supplementary Table 8)1, 2. Of 21 
unique loci, 9 yielded significant associations with three or more phenotypes (P < 0.05/21 = 
0.0024, Bonferroni correction for the number of loci). In particular, the ALDH2, C12orf51 
and BCAS3 loci had significant associations with all of the evaluated kidney function–
related traits. We also observed significant risk for CKD at several loci, including in 
MECOM, the MHC region, UNCX, WDR72, UMOD, MAF and GNAS. Because of the 
definition of CKD1, 2, previous studies assessed CKD risk primarily at the loci associated 
with serum creatinine concentration and eGFRcrea4, 6, 7, 8. However, our results suggest that 
genetic risk for CKD would also be contributed to by other kidney function–related loci, 
such as MAF and GNAS. Recent studies suggested the superiority of eGFR based on serum 
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cystatin C concentration (eGFRcys) relative to eGFRcrea, especially for predicting GFR in 
subjects with normal or mildly reduced GFR, and assessment of the genetic factors 
underlying eGFRcys in east Asians would thus be warranted.
In this study, we identified new associations at MTX1-GBA, PAX8, MECOM, the MHC 
region, UNCX, MPPED2-DCDC5, ALDH2, C12orf51, WDR72, MAF, BCAS3 and GNAS 
with kidney function–related traits. MTX1 has an essential role in embryonic development, 
and GBA encodes glucocerebrosidase, an enzyme mediating glycolipid metabolism19. Both 
are known as causal genes in Gaucher disease19, a lysosomal storage disease, although 
kidney function decline has not been implicated in pathogenesis. PAX8 is a member of the 
PAX gene family and is widely expressed in renal tissues20. MECOM (also known as EVI1) 
encodes a transcriptional regulator involved in hematopoiesis21. The MHC region contains a 
large number of genes related to the immune system, including human leukocyte antigen 
(HLA) genes. The SNP that was found to be associated with serum creatinine concentration 
and eGFRcrea (rs3828890) was located in the MHC class I region22 and was in moderate 
linkage disequilibrium with the HLA-DRB1*1302 and HLA-DQB1*0604 alleles (D′ > 0.65 
and r2 > 0.40 for both alleles)23. UNCX encodes a paired-type homeobox transcription factor 
that has essential roles in skeleton formation and kidney development24. The function of 
MPPED2 is as yet unknown, and DCDC5 encodes a protein with two doublecortin domains, 
which serve as protein-interaction platforms25. It is noteworthy that the MTX1-GBA, 
MECOM and MPPED2-DCDC5 loci have been reported to influence serum magnesium 
levels26, which are maintained by renal regulation of magnesium reabsorption. The loci in 
ALDH2, WDR72 and BCAS3 have been reported to be associated with some kidney function 
measures5, 7, although the biological roles of these genes in renal homeostasis have not been 
substantially explored. Although the function of the protein encoded by C12orf51 has not 
been examined, this locus was reported to be associated with serum lipid and liver enzyme 
concentrations in east Asians9. MAF encodes a leucine zipper transcription factor and has 
been implicated in the pathogenesis of minimal-change nephrotic syndrome (MCNS)27. 
Defects in MAF cause juvenile-onset pulverulent cataract as well as congenital cerulean 
cataract (CCA4)28. GNAS encodes the heterotrimeric G protein Gsα, and the associated 
locus in this gene is also associated with multiple metabolic traits, including blood pressure, 
in Europeans29. Nevertheless, other genes near each of the loci could also be candidates, and 
further functional assessment is desirable.
In conclusion, in this large-scale meta-analysis in east Asian populations, we identified 
multiple loci newly associated with kidney function–related traits and pleiotropic 
associations. Our study should make an important contribution to the enhanced 
understanding of the genetic architecture of kidney function.
URLs
International HapMap Project, http://hapmap.ncbi.nlm.nih.gov/; MACH and mach2qtl 
software, http://www.sph.umich.edu/csg/abecasis/MACH/index.html; IMPUTE and 
SNPTEST software, http://www.stats.ox.ac.uk/~marchini/software/gwas/gwas.html; 
BEAGLE software, http://faculty.washington.edu/browning/beagle/beagle.html; PLINK 
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software, http://pngu.mgh.harvard.edu/~purcell/plink/; R statistical software, http://cran.r-
project.org/; SNAP software, http://www.broadinstitute.org/mpg/snap/index.php.
Subjects
The 71,149 subjects included in the GWAS meta-analysis for kidney function–related traits 
(n = 57,178, 61,919, 62,087 and 33,074 for blood urea nitrogen, eGFRcrea and uric acid, 
respectively) were obtained from 18 studies conducted in the following 11 population-, 
hospital- or family-based cohorts of east Asian populations through the collaborations of 
AGEN9, 14, 15, 16: the BioBank Japan Project (BBJ), the Singapore Prospective Study 
Program (SP2), the Singapore Malay Eye Study (SiMES), the Singapore Indian Study 
(SINDI), the Singapore Chinese Eye Study (SCES), the Korea Association Resource project 
(KARE), the Health Examinee shared control study (HEXA), the Taiwan Super Control 
Study (TWSC), the Taiwan Type 2 Diabetes Consortium (TWT2D), the Genetic 
Epidemiology Network of Salt Sensitivity (GenSalt) and Cardio-metabolic Genome 
Epidemiology (CAGE). Of these, 51,327 subjects were enrolled in the GWAS meta-
analysis, and 19,822 subjects were enrolled in the in silico replication study. Some of the 
subjects were included in previous studies of east Asian populations9, 14, 15, 16. All 
participants in each cohort provided written informed consent for participation in the study, 
as approved by the ethical committees of each of the institutional review boards. Each study 
established a consensus on subject participation and phenotype definition and analytical 
protocol for the project. Detailed descriptions of the participating cohorts and the 
characteristics of the subjects are provided in Supplementary Tables 1 and 2 and in the 
Supplementary Note. Details of the European studies enrolled by the KidneyGen (n = 
23,812 for serum creatinine concentration), CKDGen (n = 67,093 for eGFRcrea) and GUGC 
(n= 110,347 for uric acid concentration) consortia, including subject details and the study 
designs, have been described at length elsewhere (refs 6, 7 and A. Köttgen et al., personal 
communication).
Genotyping and quality control
Genotyping platforms and quality control criteria, including exclusion of closely related 
subjects and outliers in terms of ancestry and cutoff values for sample call rate, SNP call 
rate, MAF and Hardy-Weinberg equilibrium P value are provided for each study 
(Supplementary Table 3 and Supplementary Note). Genotype imputation was performed on 
the basis of the HapMap Phase 2 panels (Japanese in Tokyo, Japan (JPT) and Han Chinese 
in Beijing, China (CHB) populations, except for SiMES and SINDI, for which JPT, CHB, 
Yoruba in Ibadan, Nigeria (YRI) and Utah residents of Northern and Western European 
ancestry (CEU) populations were adopted) by using MACH, IMPUTE or BEAGLE 
software (see URLs). After imputation, we excluded SNPs with MAF of <0.01 or 
imputation quality score of R2 of <0.5 from each study.
Phenotype modeling
Clinical information on the subjects, including age, gender and mean ± s.d. values for the 
kidney function–related traits, are provided (Supplementary Table 2). Collection methods 
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for the clinical information in each of the cohorts are described (Supplementary Note). In 
this study, eGFRcrea was estimated on the basis of serum creatinine levels, using the 
Japanese coefficient-modified CKD Epidemiology Collaboration (CKD-EPI) equation2. We 
excluded subjects who were <18 or >85 years old, those who had eGFRcrea of <15 ml/min/
1.73 m2 and those who had undergone renal replacement therapy. Subjects with 
gastrointestinal bleeding, systemic infection or hepatic failure and subjects who had 
undergone uric acid–lowering therapy (alloprinol, benzbromarone or probenecid) were also 
excluded from the analyses for blood urea nitrogen and uric acid concentration, respectively.
Genome-wide association study
Associations of SNPs with common log-transformed values of blood urea nitrogen (mg/dl), 
serum creatinine (mg/dl), eGFRcrea (ml/min/1.73 m2) or non-transformed values of uric 
acid concentration (mg/dl) were assessed by linear regression models assuming additive 
effects of the allele dosages of the SNPs using mach2qtl, SNPTEST, PLINK or R statistical 
software (see URLs). For the subjects in the family-based cohort, generalized linear mixed 
models accounting for the family structure were applied. In the regression model, gender, 
age, drinking status (current drinker or not), smoking status (previous or current smoker or 
not), body mass index and other cohort-specific variables were incorporated as covariates 
(Supplementary Note).
GWAS meta-analysis
In the GWAS meta-analysis, we included autosomal SNPs that satisfied quality control 
criteria in three or more GWAS for each of the traits, which yielded between 2.2 and 2.4 
million SNPs (Supplementary Table 4). Information about the SNPs, including the coded 
alleles, was oriented to the forward strand of the NCBI Build 36 reference sequence. GWAS 
meta-analysis was performed using an inverse variance–weighted method, assuming a fixed-
effects model for study-specific effect estimates (β) and standard errors (SE) of the coded 
alleles of the SNPs, using a Java source code implemented by the authors30, 31. Genomic 
control corrections were carried out on test statistics from each of the GWAS using study-
specific inflation factors (λGC) and were applied again to the results of the GWAS meta-
analysis (Supplementary Fig. 1)32.
In silico replication study
The in silico replication study was conducted using additional independent east Asian 
subjects (Supplementary Tables 1 and 2) for the loci that satisfied P < 5.0 × 10−6 in the 
GWAS meta-analysis for each of the traits (17, 14, 14 and 6 loci for blood urea nitrogen, 
serum creatinine, eGFRcrea and uric acid, respectively; Supplementary Table 5). For each of 
the loci, the SNP that showed the most significant association was selected. The associations 
of the SNPs were assessed in the same manner as in the GWAS. The combined study of the 
GWAS meta-analysis and replication was conducted using an inverse variance method, 
assuming a fixed-effects model30, 31. The SNPs that satisfied P < 5.0 × 10−8 in the combined 
study were considered to be significantly associated with the relevant kidney function–
related trait, and the associations of these SNPs were further evaluated using data in 
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European populations from the KidneyGen, CKDGen and GUGC consortia (refs 6, 7 and A. 
Köttgen et al., personal communication).
Estimation of explained variance
The interindividual variance in kidney function–related traits explained by the combination 
of the identified loci (P < 5.0 × 10−8 for each phenotype) was estimated using a genetic risk 
score model. We calculated the scores of the subjects enrolled in the in silico replication 
study by the BioBank Japan Project33 (BBJ_5 and BBJ_6; Supplementary Table 2) by 
summing the dosages of the effect alleles carried by the subjects, which were weighted by 
the effect sizes of the SNPs obtained from the GWAS meta-analysis. The explained variance 
was estimated from linear regression models on the covariate-adjusted phenotypes by the 
scores.
Pleiotropic association analysis for kidney function–related phenotypes
For the genetic loci that showed associations at P < 5.0 × 10−8 in the combined study, 
pleiotropic associations with the kidney function–related traits and with risk for stage 3+ 
CKD (defined as eGFRcrea of <60 ml/min/1.73m2)1, 2 were assessed. Associations with 
CKD risk were assessed using logistic regression models, incorporating the covariates using 
the subjects obtained from the BioBank Japan Project33 (BBJ_1– BBJ_6; Supplementary 
Table 2).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Manhattan plots of the GWAS meta-analysis for kidney function–related traits
Shown are the −log10 (P values) of the SNPs for the concentrations of blood urea nitrogen, 
serum creatinine and uric acid, and for eGFRcrea. The genetic loci that satisfied the 
genome-wide significance threshold of P < 5.0 × 10−8 (gray horizontal dotted line) in the 
combined study of the GWAS meta-analysis and replication are labeled for each of the 
traits. The newly identified loci are colored red, and the previously known loci are colored 
blue. The SNPs for which the P value was smaller than 1.0 × 10−20 are indicated at the 
upper limit of each plot.
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Figure 2. Venn diagram of pleiotropic associations of the identified loci
Genetic loci identified in the study are classified on the basis of the results of the pleiotropic 
association study of kidney function–related traits (Table 2 and Supplementary Table 8). 
Genes that showed significant associations with risk for stage 3+ CKD are colored red.
Okada et al. Page 15
Nat Genet. Author manuscript; available in PMC 2016 February 02.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Okada et al. Page 16
Ta
bl
e 
1
Lo
ci
 n
ew
ly
 a
ss
oc
ia
te
d 
w
ith
 k
id
ne
y 
fu
nc
tio
n-
re
la
te
d 
tra
its
rs
ID
a
C
hr
.
Po
sit
io
n 
(b
p)
Ba
nd
G
en
e
A
1/
A
2b
Fr
eq
.c
G
W
A
S 
m
et
a-
an
al
ys
is
R
ep
lic
at
io
n 
st
ud
y
C
om
bi
ne
d 
st
ud
y
β (
SE
)d
P
β (
SE
)d
P
β (
SE
)d
P
B
lo
od
 u
re
a 
ni
tro
ge
n 
(n 
=
 3
9,
71
7 
fo
r G
W
A
S 
m
et
a-
an
al
ys
is,
 n
 
=
 1
7,
46
1 
fo
r r
ep
lic
at
io
n)
rs
20
49
80
5
1
15
34
61
60
4
1q
22
M
TX
1-
G
BA
T/
C
0.
17
0.
00
72
(0.
00
13
)
1.
9 
× 
10
−
8
0.
00
72
(0.
00
17
)
2.
3 
× 
10
−
5
0.
00
72
(0.
00
10
)
1.
8 
× 
10
−
12
rs
11
12
31
70
2
11
36
95
41
1
2q
13
PA
X8
G
/G
0.
35
0.
00
59
(0.
00
10
)
2.
4 
× 
10
−
9
0.
00
35
(0.
00
14
)
0.
01
4
0.
00
51
(0.
00
08
)
3.
3 
× 
10
−
10
rs
16
85
37
22
3
17
06
33
32
6
3q
26
M
EC
O
M
C/
T
0.
29
0.
00
59
(0.
00
10
)
1.
3 
× 
10
−
8
0.
00
72
(0.
00
14
)
2.
7 
× 
10
−
7
0.
00
64
(0.
00
08
)
2.
7 
× 
10
−
14
rs
10
27
50
44
7
12
40
37
1
7p
22
U
NC
X
T/
A
0.
34
0.
00
79
(0.
00
15
)
1.
3 
× 
10
−
7
0.
00
53
(0.
00
19
)
0.
00
56
0.
00
69
(0.
00
12
)
4.
3 
× 
10
−
9
rs
10
76
78
73
11
30
72
52
54
11
p1
4
M
PP
ED
2-
D
CD
C5
C/
T
0.
69
0.
00
68
(0.
00
10
)
7.
0 
× 
10
−
11
0.
00
68
(0.
00
14
)
1.
4 
× 
10
−
6
0.
00
68
(0.
00
08
)
4.
5 
× 
10
−
16
rs
20
74
35
6
12
11
11
29
78
4
12
q2
4.
13
C1
2o
rf5
1
A
/G
0.
23
0.
00
64
(0.
00
13
)
4.
4 
× 
10
−
7
0.
00
63
(0.
00
20
)
0.
00
12
0.
00
64
(0.
00
11
)
1.
8 
× 
10
−
9
rs
17
73
02
81
15
51
69
52
40
15
q2
1
W
D
R7
2
G
/A
0.
58
0.
00
54
(0.
00
10
)
1.
5 
× 
10
−
8
0.
00
46
(0.
00
13
)
4.
5 
× 
10
−
4
0.
00
51
(0.
00
08
)
3.
0 
× 
10
−
11
rs
11
86
84
41
17
56
59
40
03
17
q2
3
BC
AS
3
G
/A
0.
75
0.
00
62
(0.
00
13
)
2.
1 
× 
10
−
6
0.
00
55
(0.
00
15
)
2.
2 
× 
10
−
4
0.
00
59
(0.
00
10
)
2.
1 
× 
10
−
9
rs
60
26
58
4
20
56
90
24
68
20
q1
3
G
NA
S
T/
C
0.
32
0.
00
55
(0.
00
11
)
7.
1 
× 
10
−
7
0.
00
46
(0.
00
16
)
0.
00
33
0.
00
52
(0.
00
09
)
8.
8 
× 
10
−
9
Se
ru
m
 c
re
at
in
in
e 
(n 
=
 4
2,
25
7 
fo
r G
W
A
S 
m
et
a-
an
al
ys
is,
 n
 
=
 1
9,
66
2 
fo
r r
ep
lic
at
io
n)
rs
38
28
89
0
6
31
54
86
48
6p
21
M
H
C 
re
gi
on
G
/C
0.
11
0.
00
74
(0.
00
15
)
5.
3 
× 
10
−
7
0.
00
60
(0.
00
18
)
0.
00
11
0.
00
69
(0.
00
12
)
2.
6 
× 
10
−
9
rs
10
27
71
15
7
12
51
72
1
7p
22
U
NC
X
T/
A
0.
35
0.
00
60
(0.
00
09
)
2.
2 
× 
10
−
10
0.
00
34
(0.
00
15
)
0.
02
2
0.
00
52
(0.
00
08
)
4.
6 
× 
10
−
11
rs
96
38
37
11
30
70
56
66
11
p1
4
M
PP
ED
2-
D
CD
C5
T/
C
0.
64
0.
00
36
(0.
00
07
)
7.
5 
× 
10
−
7
0.
00
40
(0.
00
12
)
0.
00
13
0.
00
37
(0.
00
06
)
3.
4 
× 
10
−
9
rs
67
1
12
11
07
26
14
9
12
q2
4.
2
AL
D
H
2
A
/G
0.
27
0.
00
47
(0.
00
09
)
5.
0 
× 
10
−
8
0.
00
40
(0.
00
13
)
0.
00
15
0.
00
45
(0.
00
07
)
2.
8 
× 
10
−
10
eG
FR
cr
ea
 (n
 
=
 4
2,
45
1 
fo
r G
W
A
S 
m
et
a-
an
al
ys
is,
 n
 
=
 1
9,
63
6 
fo
r r
ep
lic
at
io
n)
rs
38
28
89
0
6
31
54
86
48
6p
21
M
H
C 
re
gi
on
G
/C
0.
11
−
0.
00
91
(0.
00
17
)
9.
8 
× 
10
−
8
−
0.
00
62
(0.
00
20
)
0.
00
18
−
0.
00
79
(0.
00
13
)
1.
2 
× 
10
−
9
rs
10
27
71
15
7
12
51
72
1
7p
22
U
NC
X
T/
A
0.
35
−
0.
00
66
(0.
00
11
)
7.
3 
× 
10
−
10
−
0.
00
39
(0.
00
16
)
0.
01
4
−
0.
00
58
(0.
00
09
)
1.
0 
× 
10
−
10
Nat Genet. Author manuscript; available in PMC 2016 February 02.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Okada et al. Page 17
rs
ID
a
C
hr
.
Po
sit
io
n 
(b
p)
Ba
nd
G
en
e
A
1/
A
2b
Fr
eq
.c
G
W
A
S 
m
et
a-
an
al
ys
is
R
ep
lic
at
io
n 
st
ud
y
C
om
bi
ne
d 
st
ud
y
β (
SE
)d
P
β (
SE
)d
P
β (
SE
)d
P
rs
96
38
37
11
30
70
56
66
11
p1
4
M
PP
ED
2-
D
CD
C5
T/
C
0.
64
−
0.
00
41
(0.
00
08
)
6.
3 
× 
10
−
7
−
0.
00
48
(0.
00
13
)
3.
8 
× 
10
−
4
−
0.
00
43
(0.
00
07
)
1.
1 
× 
10
−
9
U
ric
 a
ci
d 
(n 
=
 2
1,
41
7 
fo
r G
W
A
S 
m
et
a-
an
al
ys
is,
 n
 
=
 1
1,
65
7 
fo
r r
ep
lic
at
io
n)
rs
88
94
72
16
78
20
34
90
16
q2
3
M
AF
C/
A
0.
57
0.
07
58
(0.
01
36
)
2.
8 
× 
10
−
8
0.
05
84
(0.
02
27
)
0.
01
0
0.
07
11
(0.
01
17
)
1.
1 
× 
10
−
9
Ch
r.,
 c
hr
om
os
om
e;
 S
E,
 st
an
da
rd
 e
rro
r, 
Fr
eq
., 
fre
qu
en
cy
.
a
SN
Ps
 in
 th
e 
ne
w
ly
 id
en
tif
ie
d 
lo
ci
 a
ss
oc
ia
te
d 
w
ith
 k
id
ne
y 
fu
nc
tio
n-
re
la
te
d 
tra
its
.
b T
he
 a
lle
le
 th
at
 in
cr
ea
se
d 
bl
oo
d 
ur
ea
 n
itr
og
en
, s
er
um
 c
re
at
in
in
e 
or
 u
ric
 a
ci
d 
co
nc
en
tra
tio
n 
or
 th
at
 d
ec
re
as
ed
 e
G
FR
cr
ea
 w
as
 d
ef
in
ed
 a
s a
lle
le
 1
 (A
l) 
an
d i
s i
nd
ica
ted
 on
 th
e b
asi
s o
f t
he
 fo
rw
ard
 st
ran
d o
f N
CB
I 
B
ui
ld
 3
6.
c F
re
qu
en
cy
 o
f a
lle
le
 1
 in
 th
e 
G
W
A
S 
m
et
a-
an
al
ys
is.
d E
ffe
ct
 si
ze
 o
f a
lle
le
 1
 o
n 
co
m
m
on
 lo
g-
tra
ns
fo
rm
ed
 v
al
ue
s o
f b
lo
od
 u
re
a 
ni
tro
ge
n 
or
 se
ru
m
 c
re
at
in
in
e 
co
nc
en
tra
tio
n,
 e
G
FR
cr
ea
 o
r n
on
-tr
an
sf
or
m
ed
 v
al
ue
s o
f u
ric
 a
ci
d 
co
nc
en
tra
tio
n.
Nat Genet. Author manuscript; available in PMC 2016 February 02.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Okada et al. Page 18
Ta
bl
e 
2
Pl
ei
ot
ro
pi
c 
as
so
ci
at
io
ns
 o
f t
he
 id
en
tif
ie
d 
lo
ci
 w
ith
 k
id
ne
y 
fu
nc
tio
n–
re
la
te
d 
tra
its
 a
nd
 C
K
D
 ri
sk
Bl
oo
d 
ur
ea
n
itr
og
en
(n
 
=
 5
7,
17
8)
Se
ru
m
cr
ea
tin
in
e
(n
 
=
 6
1,
91
9)
eG
FR
cr
ea
(n
 
=
 6
2,
08
7)
U
ri
c a
ci
d
(n
 
=
 3
3,
07
4)
C
K
D
(8,
80
5 c
as
es 
an
d
35
,2
59
 co
nt
ro
ls)
Pb
Pb
Pb
Pb
Pb
rs
20
49
80
5
1
15
34
61
60
4
1q
22
M
TX
1-
G
BA
1.
8 
× 
10
−
12
0.
02
7
0.
04
6
0.
00
22
0.
75
rs
11
12
31
70
2
11
36
95
41
1
2q
13
PA
X8
3.
3 
× 
10
−
10
0.
00
59
0.
00
82
0.
07
9
0.
00
58
rs
13
06
90
00
3
66
88
16
40
3p
14
LR
IG
1-
KB
TB
D
8
1.
4 
× 
10
−
19
0.
24
0.
42
0.
00
93
0.
94
rs
16
85
37
22
3
17
06
33
32
6
3q
26
M
EC
O
M
2.
7 
× 
10
−
14
9.
4 
× 
10
−
4
8.
3 
× 
10
−
4
0.
76
9.
9 
× 
10
−
4
rs
10
93
73
29
3
18
91
96
41
2
3q
27
BC
L6
-L
PP
8.
8 
× 
10
−
30
0.
90
0.
93
0.
36
0.
40
rs
37
75
94
8
4
96
04
28
0
4p
16
SL
C2
A9
0.
06
1
0.
40
0.
36
1.
6 
× 
10
−
65
0.
13
rs
13
14
63
55
4
77
63
11
64
4q
21
SH
RO
O
M
3
0.
04
3
9.
4 
× 
10
−
12
6.
6 
× 
10
−
11
0.
16
0.
09
0
rs
27
25
22
0
4
89
17
89
46
4q
22
AB
CG
2
0.
20
0.
18
0.
23
4.
2 
× 
10
−
30
0.
44
rs
38
28
89
0
6
31
54
86
48
6p
21
M
H
C 
re
gi
on
0.
14
2.
6 
× 
10
−
9
1.
2 
× 
10
−
9
0.
05
1
0.
00
16
rs
19
36
80
0
6
12
74
77
75
7
6q
22
RS
PO
3
1.
2 
× 
10
−
11
0.
64
0.
57
0.
78
0.
72
rs
10
27
71
15
7
12
51
72
1
7p
22
U
NC
X
1.
9 
× 
10
−
9
4.
6 
× 
10
−
11
1.
0 
× 
10
−
10
0.
01
4
1.
7 
× 
10
−
6
rs
10
76
78
73
11
30
72
52
54
11
p1
4
M
PP
ED
2-
D
CD
C5
4.
5 
× 
10
−
16
4.
3 
× 
10
−
7
1.
8 
× 
10
−
7
0.
01
2
0.
00
55
rs
50
49
15
11
64
22
06
61
11
q1
3
SL
C2
2A
12
0.
68
0.
32
0.
39
3.
3 
× 
10
−
63
0.
74
rs
67
1
12
11
07
26
14
9
12
q2
4.
2
AL
D
H
2
1.
3 
× 
10
−
5
2.
8 
× 
10
−
10
7.
8 
× 
10
−
8
1.
6 
× 
10
−
6
0.
16
rs
20
74
35
6
12
11
11
29
78
4
12
q2
4.
13
C1
2o
rf5
1
1.
8 
× 
10
−
9
1.
9 
× 
10
−
9
6.
5 
× 
10
−
8
1.
6 
× 
10
−
5
0.
14
rs
17
73
02
81
15
51
69
52
40
15
q2
1
W
D
R7
2
3.
0 
× 
10
−
11
3.
6 
× 
10
−
14
1.
3 
× 
10
−
13
0.
29
1.
3 
× 
10
−
8
rs
11
86
49
09
16
20
30
83
40
16
p1
2
U
M
O
D
0.
00
58
1.
1 
× 
10
−
10
3.
6 
× 
10
−
10
0.
87
7.
0 
× 
10
−
4
rs
88
94
72
16
78
20
34
90
16
q2
3
M
AF
0.
30
0.
29
0.
30
1.
1 
× 
10
−
9
0.
00
12
rs
11
86
84
41
17
56
59
40
03
17
q2
3
BC
AS
3
2.
1 
× 
10
−
9
0.
01
0
0.
00
98
0.
00
89
0.
06
2
rs
98
95
66
1
17
56
81
13
71
17
q2
3
BC
AS
3
0.
65
7.
4 
× 
10
−
11
4.
8 
× 
10
−
11
9.
3 
× 
10
−
4
0.
00
60
rs
72
27
48
3
18
41
44
11
28
18
q1
2
SL
C1
4A
2
6.
7 
× 
10
−
18
0.
32
0.
32
0.
03
3
0.
11
rs
60
26
58
4
20
56
90
24
68
20
q1
3
G
NA
S
8.
8 
× 
10
−
9
0.
19
0.
10
0.
00
41
0.
00
22
D
et
ai
le
d 
re
su
lts
 o
f t
he
 a
na
ly
sis
 a
re
 p
ro
vi
de
d 
in
 S
up
pl
em
en
ta
ry
 T
ab
le
 8
.
a
In
di
ca
te
d 
on
 th
e 
ba
sis
 o
f t
he
 fo
rw
ar
d 
str
an
d 
of
 N
CB
I B
ui
ld
 3
6.
Nat Genet. Author manuscript; available in PMC 2016 February 02.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Okada et al. Page 19
b P
 
v
al
ue
s t
ha
t s
at
isf
ie
d 
th
e 
Bo
nf
er
ro
ni
 c
or
re
ct
io
n 
ba
se
d 
on
 th
e 
nu
m
be
r o
f l
oc
i (
α 
=
 0
.0
5,
 n
 
=
 2
1;
 P
 
<
 0
.0
02
4) 
are
 sh
ow
n i
n b
old
.
Nat Genet. Author manuscript; available in PMC 2016 February 02.
